47QTCB22D0095-75F40122F80271
Delivery Order
Overview
Government Description
FDA Capital Planning Investment Control (CPIC)
Awardee
Awarding / Funding Agency
Place of Performance
Reston, VA 20190 United States
Pricing
Labor Hours
Set Aside
8(A) Competed (8A)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Related Opportunity
(Parent Award)
Analysis Notes
DOGE This delivery order was on the Department of Government Efficiency (DOGE) termination list as of July 2025. See All
Termination This delivery order was terminated for convenience (partial or complete) in April 2026.
Amendment Since initial award the Potential End Date has been shortened from 01/31/26 to 09/05/25.
Termination This delivery order was terminated for convenience (partial or complete) in April 2026.
Amendment Since initial award the Potential End Date has been shortened from 01/31/26 to 09/05/25.
Metaphase Consulting was awarded
Delivery Order 75F40122F80271 (75F401-22-F-80271)
for Fda Capital Planning Investment Control (CPIC)
worth up to $2,161,412
by the FDA Office of Acquisition and Grant Services
in August 2022.
The contract
has a duration of 3 years 1 months and
was awarded
with a 8(a) set aside
with
NAICS 541512 and
PSC DF01
via subject to multiple award fair opportunity acquisition procedures with 1 bid received.
This contract was awarded through vehicle 8a STARS III - Base.
Status
(Closed)
Last Modified 4/9/26
Period of Performance
8/1/22
Start Date
9/5/25
Current End Date
9/5/25
Potential End Date
Obligations
$2.2M
Total Obligated
$2.2M
Current Award
$2.2M
Potential Award
Award Hierarchy
Vehicle
Governmentwide Acquisition Contract
Delivery Order
47QTCB22D0095-75F40122F80271
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 47QTCB22D0095-75F40122F80271
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2022 | $146,807 | 1,139.0 | 0.6 | $128.89 |
| 2023 | $734,998 | 5,669.0 | 2.7 | $129.65 |
| 2024 | $814,198 | 6,222.8 | 3.0 | $130.84 |
Transaction History
Modifications to 47QTCB22D0095-75F40122F80271
People
Suggested agency contacts for 47QTCB22D0095-75F40122F80271
Competition
Number of Bidders
1
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
ZH8ACM4ZWDL7
Awardee CAGE
72XV7
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsjuliettewilliams
Last Modified By
hhsrwalker1
Approved By
hhsrwalker1
Legislative
Legislative Mandates
Clinger-Cohen Act Compliant
Performance District
VA-11
Senators
Mark Warner
Timothy Kaine
Timothy Kaine
Representative
Gerald Connolly
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| FDA Working Capital Fund, Food and Drug Administration, Health and Human Services (075-4613) | Consumer and occupational health and safety | Other services from non-Federal sources (25.2) | $1,209,358 | 100% |
Modified: 4/9/26